Pediatrics Doctors in Seneca, PA Accepting Medicare

7 Pediatrics doctors found. Showing 1 - 7

Grace Esare-nkrumah, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 100 Fairfield Dr, Seneca, PA 16346 Phone: 814-676-7863    Fax: 814-676-7975

Heidi Ochs, Pediatrics Medicare: Medicare Enrolled Practice Location: 100 Fairfield Dr, Seneca, PA 16346 Phone: 814-676-7932

Ellen Smith, Pediatrics Medicare: Medicare Enrolled Practice Location: 100 Fairfield Dr, Seneca, PA 16346 Phone: 814-676-7863

Dr. Jennifer Michelle Bishop, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3512 State Route 257 Ste 108, Seneca, PA 16346 Phone: 814-677-3717    Fax: 814-677-8914

Dr. Linda G Caballero-goehringer, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3512 Sr 257 Ste 107, Seneca, PA 16346 Phone: 814-670-0260    Fax: 814-253-2600

Muhammad Badar Munir, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 100 Fairfield Dr, Seneca, PA 16346 Phone: 814-676-7863

Dr. Glenn Gordon Hamm, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3512 State Route 257, Suite 106, Seneca, PA 16346 Phone: 814-677-3717    Fax: 814-677-8914

News Archive

Agalimmune established to develop innovative immunotherapeutics for treatment of cancer

Agalimmune Ltd, a biopharmaceutical company, has been created to develop innovative immunotherapeutics for the treatment of cancer, with a focus on solid tumours.

New algorithm eliminates exposure to radiation when diagnosing children with acute appendicitis

Implementation of an algorithm aimed to diagnose pediatric patients with suspected appendicitis reduces the utilization of computed tomography (CT) scans, without affecting diagnostic accuracy, Mayo Clinic Children's Center researchers have found. The study was recently published in the journal Surgery.

GlycoMimetics highlights clinical, preclinical progress of GMI-1070 in sickle cell crisis at ASH 2010

GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced that two oral presentations and two abstracts were delivered at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida. The presentations and abstracts highlighted clinical and preclinical progress with GlycoMimetics's lead compound GMI-1070, now in Phase 2 clinical trials in sickle cell crisis.

Neora introduces innovative product to treat acne

Neora, a leader in providing science-based, rejuvenating skincare and wellness products, announces a new addition to its product portfolio, Complexion Clearing Acne Treatment Pads.

Read more Medical News

› Verified 3 days ago